RHKU.F RHOEN-KLINIK.UNSP.ADR 1/2
- Market cap
- EUR 930M
- P/E
- 21.7x
- P/B
- 0.69x
- ROE
- 3.1%
- Dividend yield
- 0.72%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is RHKU.F undervalued?
Graham numberRHKU.F trades 18.4% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
RHOEN-KLINIK.UNSP.ADR 1/2 fundamental analysis
No fundamental analysis for RHOEN-KLINIK.UNSP.ADR 1/2 yet.
RHOEN-KLINIK.UNSP.ADR 1/2 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About RHOEN-KLINIK.UNSP.ADR 1/2
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.
Full company profileRHOEN-KLINIK.UNSP.ADR 1/2 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
RHOEN-KLINIK.UNSP.ADR 1/2 annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 1.40B | 1.45B | 1.46B | 1.60B | 1.70B | 1.74B |
| Gross Profit | 198M | 199M | 149M | 172M | 193M | 1.55B |
| Operating Income | 29.7M | 36.3M | 29.6M | 37.5M | 29.0M | 53.7M |
| EBITDA | - | 107M | 117M | 122M | 113M | 119M |
| Net Income | 28.3M | 25.1M | 38.7M | 43.4M | 34.5M | 42.1M |
| EPS | 0.42 | 0.38 | 0.58 | 0.65 | 0.51 | 0.63 |
| Balance Sheet | ||||||
| Total Assets | 1.67B | 1.70B | 1.77B | 1.86B | 1.82B | 1.83B |
| Total Liabilities | 441M | 454M | 490M | 531M | 468M | 463M |
| Shareholders' Equity | 1.20B | 1.22B | 1.25B | 1.30B | 1.32B | 1.34B |
| Cash & Short-term Investments | 126M | 77.3M | 206M | 280M | 170M | 119M |
| Cash Flow | ||||||
| Operating Cash Flow | 97.5M | 60.3M | 109M | 128M | 57.2M | - |
| Capital Expenditure | 77.8M | 58.2M | 62.8M | 70.4M | 99.1M | 0.00 |
| Free Cash Flow | 19.7M | 2.10M | 46.2M | 57.2M | -41.9M | - |
| Ratios | ||||||
| ROE | 2.4% | 2.1% | 3.1% | 3.3% | 2.6% | 3.1% |
| ROA | 1.7% | 1.5% | 2.2% | 2.3% | 1.9% | 2.3% |
| Net Profit Margin | 2.0% | 1.7% | 2.6% | 2.7% | 2.0% | 2.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
RHOEN-KLINIK.UNSP.ADR 1/2 dividends
- Dividend yield
- 0.72%
- Forward dividend
- 0.10 EUR
- Payout ratio
- 19.4%
- Ex-dividend date
- May 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 6.70M | 0.10 | 19.4% |
| 2024 | - | - | - |
| 2023 | EUR 10.0M | 0.15 | 25.8% |
| 2022 | - | - | - |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns RHOEN-KLINIK.UNSP.ADR 1/2
Ownership data of RHOEN-KLINIK.UNSP.ADR 1/2 is not available yet.
RHOEN-KLINIK.UNSP.ADR 1/2 company profile
- Company name
- RHOEN-KLINIK.UNSP.ADR 1/2
- Ticker
- RHKU.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 14,144
- Fiscal year end
- December
- Address
- Salzburger Leite 1, Bad Neustadt an der Saale, Germany, 97616
- Phone
- 49 9771 65 0
- Website
- rhoen-klinikum-ag.com
About RHOEN-KLINIK.UNSP.ADR 1/2
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.
RHOEN-KLINIK.UNSP.ADR 1/2 management
3- Dr. Stefan Stranz Ph.D.CFO & Member of Management Board · born 1977
- Dr. Gunther Karl Weiß M.Sc.COO & Member of Management Board · born 1966
- Mr. Julian SchmittHead of Investor Relations & Treasury